Dx & Vx Co Ltd

180400

Company Profile

  • Business description

    Dx & Vx Co Ltd is a bio-healthcare company operating in the following business segments: Medical Diagnosis, Healthcare, and New Drug Development. The majority of its revenue is generated from the Healthcare segment, which utilizes diagnostic technology to provide integrated biohealthcare solutions for microbiome-based diseases, and offers health functional foods for prevention, over-the-counter and prescription drugs for treatment, and lifestyle and hygiene products for management. The Medical Diagnosis segment provides preimplantation, prenatal, neonatal, and adult genomic testing and microbiome analysis services, and the New Drug Development business is involved in the research and development of COVID vaccines and treatment, microbiome respiratory vaccine, and mRNA anticancer vaccine.

  • Contact

    173 Digital-ro
    1003, 10th Floor, Elysia Building
    Geumcheon-gu
    Gasan-dong
    Seoul
    KOR

    T: +82 28908700

    https://www.dxvx.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2026

    Employees

    89

Stocks News & Analysis

stocks

Cheap ASX share may have more room to run

Shares are cheap despite rebounding share price, yet risks remain.
stocks

ASX listed media giant drives strong earnings growth

Digital growth drives earnings beat for media share.
stocks

ASX real estate platform outperforms yet questions remain

Valuation remains a key concern despite strong August reporting.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,416.6020.80-0.22%
CAC 408,714.9315.220.17%
DAX 4026,319.45179.320.69%
Dow JONES (US)54,036.93151.830.28%
FTSE 10010,901.0933.200.31%
HKSE25,824.44156.410.61%
NASDAQ26,690.62342.261.30%
Nikkei 22566,986.121,379.412.10%
NZX 50 Index13,853.4229.290.21%
S&P 5007,757.6447.680.62%
S&P/ASX 2009,227.2022.40-0.24%
SSE Composite Index3,962.4422.400.57%

Market Movers